CVE-2024-13026

Inadequate Encryption Strength Vulnerability in Roche Algo Edge

Description

A vulnerability exists in Algo Edge up to 2.1.1 - a previously used (legacy) component of navify® Algorithm Suite. The vulnerability impacts the authentication mechanism of this component and could allow an attacker with adjacent access to the laboratory network and the Algo Edge system to craft valid authentication tokens and access the component. Other components of navify® Algorithm Suite are not affected.

Category

6.1
CVSS
Severity: Medium
CVSS 4.0 •
EPSS 0.03%
Vendor Advisory roche.com
Affected: Roche Diagnostics Algorithm Suite
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2024-13026?
CVE-2024-13026 has been scored as a medium severity vulnerability.
How to fix CVE-2024-13026?
To fix CVE-2024-13026, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-13026 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2024-13026 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-13026?
CVE-2024-13026 affects Roche Diagnostics Algorithm Suite.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.